Terminated NA INTERVENTIONAL 2-arm NCT05790460

Telehealth Based Synchronous Navigation to Improve Molecularly-Informed Care for Patients With Lung Cancer (TESTING)

Sponsor: Abramson Cancer Center at Penn Medicine

Interventions Telehealth

Updated 7 times since 2023 Last updated: Apr 3, 2025 Started: May 8, 2023 Primary completion: Jan 11, 2024 Completion: Nov 9, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient accrual

Other terminated trials from Abramson Cancer Center at Penn Medicine

See all terminations from Abramson Cancer Center at Penn Medicine

Other Non-small Cell Lung Cancer trials with similar outcome

Browse all Non-small Cell Lung Cancer trials

A NA clinical study on Non-small Cell Lung Cancer, this trial is terminated or withdrawn. The trial is conducted by Abramson Cancer Center at Penn Medicine and has accumulated 7 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

May 2025 — Present [monthly]

Terminated NA
Sep 2024 — May 2025 [monthly]

Terminated NA
Aug 2024 — Sep 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jul 2024 — Aug 2024 [monthly]

Recruiting NA
Jun 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

May 2023 — Jun 2023 [monthly]

Not Yet Recruiting NA
Apr 2023 — May 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)

Data source: Abramson Cancer Center at Penn Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States